Pharmaceutical

EMA CHMP endorses Mirum Pharmaceuticals’ LIVMARLI for PFIC

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended Mirum Pharmaceuticals’ LIVMARLI.

Jun 4, 2024 - 04:00
EMA CHMP endorses Mirum Pharmaceuticals’ LIVMARLI for PFIC
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended Mirum Pharmaceuticals’ LIVMARLI.
Read the original article

Tags:

Previous Article

CHMP approves backing for first acanthamoeba keratitis treatment

Next Article

Inline, real-time PAT tool is a game-changer for pharma granulation sector

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: Medicare has different standards than the FDA. That’s how it should be

Opinion: Medicare has different standards than the FDA....

Feb 3, 2024

BridgeBio secures $1.25bn for genetic therapy development

BridgeBio secures $1.25bn for genetic therapy development

Jan 19, 2024

STAT+: AbbVie purchases neuroscience developer Cerevel for $8.7 billion

STAT+: AbbVie purchases neuroscience developer Cerevel ...

Dec 7, 2023